Astex Pharmaceuticals, Inc 4
4 · Astex Pharmaceuticals, Inc · Filed Oct 16, 2013
Insider Transaction Report
Form 4
Fellner Peter
Director
Transactions
- Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−20,000→ 0 totalExercise: $2.10Exp: 2022-06-22→ Common Stock (20,000 underlying) - Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−50,000→ 0 totalExercise: $2.94Exp: 2021-07-20→ Common Stock (50,000 underlying)
Footnotes (6)
- [F1]The option originally provided for vesting as to 20% of the shares on July 20, 2011 and each one year anniversary thereafter. Pursuant to the Agreement and Plan of Merger, dated September 5, 2013, between the Issuer, Otsuka Pharmaceutical Co., Ltd., and Autumn Acquisition Corporation (the "Merger Agreement"), the option vested in full immediately prior to the closing of the merger.
- [F2]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $278,000.00, which represents the difference between $8.50 and the exercise price of the option per share.
- [F3]The option provided for vesting as to 1/4th of the shares on June 22, 2012 and on each three month anniversary thereafter.
- [F4]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $128,000.00, which represents the difference between $8.50 and the exercise price of the option per share.
- [F5]The option originally provided for vesting as to 1/4th of the shares on June 13, 2013 and on each three month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
- [F6]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $78,000.00, which represents the difference between $8.50 and the exercise price of the option per share.